Skip to main content

Legato Capital Management LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1442641 San Francisco, CA

Position in BCRX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$828,335
+$641,533 QoQ
Shares Held
87,010
+263.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Legato Capital Management LLC holds $15,801,793 across 13 Drug Manufacturers - Specialty & Generic names. BCRX ranks #7 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 BCRX
Biocryst Pharmaceuticals Inc
This page
87,010 $828,335

All Filings in BCRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $828,335 87,010
2025-12-31 $186,802 23,949
2025-09-30 $165,287 21,777
2025-06-30 $195,121 21,777
2025-03-31 $165,915 22,122
2024-12-31 $177,419 23,593
2024-09-30 $179,306 23,593
2024-06-30 $145,804 23,593
2024-03-31 $117,983 23,225
2023-12-31 $139,117 23,225
2023-09-30 $164,433 23,225